Phio Pharmaceuticals
PHIO
#10946
Rank
NZ$16.66 M
Marketcap
NZ$1.39
Share price
-5.03%
Change (1 day)
-39.98%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -NZ$22.47 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$15.74 Million a decrease over its 2024 earnings that were of -NZ$12.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$22.47 Million42.8%
2025 -NZ$15.74 Million21.65%
2024 -NZ$12.94 Million-33.96%
2023 -NZ$19.59 Million-5.7%
2022 -NZ$20.77 Million-13.6%
2021 -NZ$24.04 Million51.09%
2020 -NZ$15.91 Million-1.28%
2019 -NZ$16.12 Million21.03%
2018 -NZ$13.32 Million-53.1%
2017 -NZ$28.39 Million74.49%
2016 -NZ$16.27 Million-12.02%
2015 -NZ$18.5 Million16.17%
2014 -NZ$15.92 Million-57.95%
2013 -NZ$37.85 Million62.45%
2012 -NZ$23.3 Million0.87%
2011 -NZ$23.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.29 Billion 1,133.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.85 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA